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An improved, cost effective process for the synthesis of N,N-diisopropyl-3-(2-hydroxy-5-methylphenyl)-3-
phenylpropanamide; a key intermediate for the preparation of Tolterodine and its related substances were
described. The process features one pot synthesis employing inexpensive reagents.
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Tolterodine is chemically known as (R)-N,N-disiopropyl-
3-(2-hydroxy-5-methyl phenyl)-3-phenyl propyl amine.
Tolterodine acts as a muscarinic receptor antagonist. It is
useful in the treatment of urinary incontinence [1]. Tolter-
odine tartrate acts by relaxing the smooth muscle tissues
in the walls of the bladder by blocking cholinergic recep-
tors [2]. Tolterodine tartrate [3] is marketed by Pharmacia
& Upjohn in the brand name of Destrol®.
The present invention relates to a novel process for the
preparation of N,N-diisopropyl-3-(2-hydroxy-5-methyl-
phenyl)-3-phenylpropanamide (4); a key intermediate
for the preparation of Tolterodine (1). Some different
approaches have been published [4-8] for the prepar-
ation of N,N-diisopropyl-3-(2-hydroxy-5-methylphenyl)-3-
phenylpropanamide (4). These methods involve multistep
synthesis using hazardous, expensive reagents and some
of the methods [6] involve activators like Grignard re-
agents, LDA, n-butyl lithium, Lewis acids. Hence there
is a need to develop an alternative, plant friendly pro-
cedure for the preparation of N,N-diisopropyl-3-(2-* Correspondence: srinivasgaraga@yahoo.com
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otherwise stated.hydroxy-5-methylphenyl)-3-phenylpropanamide (4) from
3,4-dihydro-6-methyl-4-phenylcoumarin (2) (Figure 1).
Results and discussion
Ring opening reactions of dihydrocoumarins are well
known in literature [9-11]. But in the present invention, we
have described a new methodology (Scheme 1 & Scheme 2)
for the preparation of N,N-diisopropyl-3-(2-hydroxy-5-
methylphenyl)-3-phenylpropanamide (4) by using inex-
pensive and commercially vailable starting materials like
3, 4-dihydro-6-methyl 4-phenylcoumarin (2), which was
synthesized from p-cresol and trans-cinnamic acid [12].
3,4-Dihyhydro-6-methyl 4-phenylcoumarin (2) reacts
with diisopropylamine (6) in presence of acetic acid
gives N,N-diisopropyl-3-(2-hydroxy-5-methylphenyl)-
3-phenylpropanamide (4) at room temperature. This
process of compound 4 is very useful for commercialization
of Tolterodine 1 in plant.
In order to optimize the yields, this reaction was studied
in different solvents like Dichloromethane, Tetrahydrofuran,
Acetonitrile, Toluene, Ethanol, Methanol and Diisopropy-
lether. The reaction parameters are tabulated in Table 1.
In methanol, methyl 3-(2-hydroxy-5-methylphenyl)-3-
phenylpropanoate (3) was observed as an intermediate,
which is not completely converted to amide (4). Hence
the yield was found low. Among, diisopropylether was
found to be the best suitable solvent for the preparation ofral Ltd. This is an Open Access article distributed under the terms of the Creative
commons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited. The Creative Commons Public Domain Dedication





























































Scheme 2 N-Isopropyl-3-(2-hydroxy-5-methylphenyl)-3-phenylpropanamide 5.
Table 1 Screening of solvent for the synthesis of
compound 4
Entry Coumarin Amine Solvent Temparature Yield (%)c
1. 2 DIPAa DCM Reflux No
reaction
2. 2 DIPA THF Reflux No
reaction
3. 2 DIPA ACN Reflux No
reaction
4. 2 DIPA ACN Sealed tubeb 15
5. 2 DIPA Methanol 25-30°C 15
6. 2 DIPA Methanol Reflux 15
7. 2 DIPA Ethanol Reflux 10
8. 2 DIPA Toluene Reflux 30
9. 2 DIPA Diisopropylether 25-30°C 53
aN.N-diisopropylamine (DIPA), for all the above reactions 5 mole equivalents of
DIPA used. bpressure reaction performed at 110°C. cisolated yields.
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propanamide (4), which results maximum yields of 53%.
In our continuous research, this reaction was further
studied with acetic acid as a catalyst in diisopropylether.
The experiments details are tabulated in Table 2. Based
on the results, we observed the yield of compound 4
was increased to 75%, when 4 mole equivalents of acetic
acid was used. But our attempts to increase the yield of
compound 4 further by adding more equivalents of aceticTable 2 Screening of catalyst for the synthesis of
compound 4
Entry Coumarin Catalyst Moles Temparature Yield (%)a
1. 2 Acetic acid 1 25-30°C 50
2. 2 Acetic acid 2 25-30°C 55
3. 2 Acetic acid 3 25-30°C 57
4. 2 Acetic acid 4 25-30°C 75
5. 2 Acetic acid 5 25-30°C 75
aisolated yields.
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acid, we observed lower yields of compound 4.
Compound 4 is known in literature [4-12]. Compounds
4a-4c and 5-5c are novel. These compounds upon reduc-
tion [4-12] with LiAlH4, Vitride, Sodium borohydride gives
corresponding amines, which are useful in the synthesis of
Tolterodine and its related compounds.
Conclusion
An efficient, synthesis of N,N-diisopropyl-3-(2-hydroxy-
6-methylphenyl)-3-phenylpropanamide was achieved
by one pot synthesis between 3,4-dihydro-6-methyl-4-
phenylcoumarin and diisopropylamine.
Experimental
Solvents and reagents were obtained from commercial
source and used without purification. The IR spectra
(ϑmax, cm-1) were recorded in solid state KBr dispersion
using Perkin Elmer FT-IR spectrometer. The 1H NMR
and 13C NMR spectra were recorded on Bruker-Avance
300 MHz spectrometer. The chemical shifts were reportedTable 3 Novel analogues of compound 4




4c DIPAin δ/ ppm relative to TMS. The mass spectra were recorded
on API 2000 Perkin Elmer PE-Sciex mass spectrometer.
The reactions were monitored by Thin–layer chromatog-
raphy (TLC). Melting points were determined by polman
melting point apparatus (Model No MP96), open capillary
method and are uncorrected.
General procedure for the synthesis of compounds 4-4c
& 5-5c
To a solution of 3,4-dihyhydro-6-methyl 4-phenylcoumarin
2 (10 g, 42 mmol) in diisopropylether (200 mL), N,N-
diisopropylamine (33.95 g, 336 mmol) and acetic acid
(10 g, 168 mmol) were added at room temperature. The
suspension was stirred for 16 h at room temperature. The
reaction mass was concentrated, the resulting residue was
crystallized with D.M.Water (50 mL) and diisopropyl ether
(50 mL) mixture to gave N,N-diisopropyl-3-(2-hydroxy-5-
methylphenyl)-3-phenylpropanamide 4 (10.6 g, 75% yield).
This methodology was extended to make similar ana-
logues 4-4c and 5-5c of compound 4 and 5. The analogues
were summarized in Tables 3 & 4.uct Melting range Yield




Table 4 novel analogues of compound 5 (Scheme 2)
Entrty Coumarin Amine Product Melting range Yield
5 MIPAa 136-139°C 98%
5a MIPA 132-136°C 88%
5b MIPA 162-166°C 97%
5c MIPA 125-128°C 90%
aIsopropylamine.
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phenylpropanamide 4
IR (KBr) cm-1: 3024 (Aromatic C-H, str.), 2949, 2904, 2869
(Aliphatic C-H, str.), 1630 (C═O, str.), 1609, 1555, 1510
(C═C, str.), 1469, 1459 (CH2 bending), 1270 (C-N, str.),
1072 (C-O, str.), 788, 769 (Aromatic CH Out-of-plane
bend). 1H NMR (300 MHz, DMSO-d6) δ 1.04 (d, 12H),
2.089 (s, 3H), 2.79 (m, 2H), 3.037 (m, 2H), 4.702 (t, 1H), 6.6
(d, 1H), 6.75 (d, 2H), 7.127-7.246 (m, 5H). 13C NMR
(125 MHz, DMSO-d6) δ 19.39, 20.36, 45.69, 115.33, 125.70,




IR (KBr), cm-1: 3030 (Aromatic C-H, str.), 2977, 2932, 2872
(Aliphatic C-H, str.), 1628 (C═O, str.), 1605, 1556, 1509
(C═C, str.), 1496, 1453 (CH2 bending), 1270 (C-N, str.),
1081 (C-O, str.), 790,753 (Aromatic CH Out-of-planebend). 1H NMR (300 MHz, DMSO-d6) δ 0.9 (m, 6H),
2.16 (s, 3H), 2.69 (m, 2H), 3.69 (m, 1H), 4.74 (t, 1H), 6.6
(d, 1H), 6.76 (d, 2H), 7.08-7.2 (m, 5H), 7.64 (d, 1H). 13C
NMR (125 MHz, DMSO-d6) δ 20.37, 22.30, 39.17,
39.50, 39.70, 39.90, 40.00, 40.71, 114.98, 125.54, 126.91,
127.11, 127.81, 128.15, 130.11, 144.48, 152.21, 169.38. MS
m/z: 298 [(M +H)+].
N,N-diisopropyl-3-(2-hydroxy-4-methylphenyl)-3-
phenylpropanamide 4a
IR (KBr) cm-1: 3024 (Aromatic C-H, str.), 2984, 2950,
2863 (Aliphatic C-H, str.), 1625 (C═O, str.), 1567, 1493
(C═C, str.), 1470, 1427 (CH2 bending), 1282 (C-N, str.),
1072 (C-O, str.), 781,762 (Aromatic CH Out-of-plane
bend). 1H NMR (300 MHz, DMSO-d6) δ 1.04 (d, 12H),
2.089 (s, 3H), 2.79 (m, 2H), 3.037 (m, 2H), 4.702 (t, 1H),
6.6 (d, 1H), 6.75 (d, 2H), 7.127-7.246 (m, 5H). 13C NMR
(125 MHz, DMSO-d6) δ 20.18, 20.60, 39.0, 39.17, 39.34,
39.50, 39.67, 39.77, 39.84, 40.0, 42.59, 45.22, 116.72,
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174.71. MS m/z: 340 [(M +H)+].
N-Isopropyl-3-(2-hydroxy-4-methylphenyl)-3-
phenylpropanamide 5a
IR (KBr) cm-1: 3026 (Aromatic C-H, str.), 2977, 2934, 2874
(Aliphatic C-H, str.), 1627 (C═O, str.), 1610, 1589, 1543
(C═C, str.), 1492, 1449 (CH2 bending), 1245 (C-N, str.),
1074 (C-O, str.), 780,756 (Aromatic CH Out-of-plane
bend). 1H NMR (300 MHz, DMSO-d6) δ 0.9 (m, 6H),
2.16 (s, 3H), 2.69 (m, 2H), 3.69 (m, 1H), 4.74 (t, 1H),
6.6 (d, 1H), 6.76 (d, 2H), 7.08-7.2 (m, 5H), 7.64 (d,1H).
13C NMR (125 MHz, DMSO-d6) δ 0.65, 22.30, 39.17,
39.33, 39.50, 39.67, 39.83, 40.0, 40.74, 115.76, 119.40,
125.51, 127.57, 127.78, 135.95, 144.60, 154.33, 169.42.
MS m/z: 298 [(M + H)+].
N,N-diisopropyl-3-(2-hydroxy-3-methylphenyl)-3-
phenylpropanamide 4b
IR (KBr), cm-1: 3030 (Aromatic C-H, str.), 2952, 2920, 2877
(Aliphatic C-H, str.),1629 (C═O, str.), 1592, 1548, 1495
(C═C, str.), 1466, 1418 (CH2 bending), 1265 (C-N, str.),
1067.7 (C-O, str.), 780, 769 (Aromatic CH Out-of-plane
bend). 1H NMR (300 MHz, DMSO-d6) δ 1.04 (d, 12H),
2.089 (s, 3H), 2.79 (m, 2H), 3.037 (m, 2H), 4.702 (t, 1H),
6.6 (d, 1H), 6.75 (d, 2H), 7.127-7.246 (m, 5H). 13C NMR
(125 MHz, DMSO-d6) δ 16.6, 16.81, 19.09, 19.14, 40.01,
43.93, 45.64, 118.75, 125.99, 127.66, 128.10, 133.33, 145.66,
153.17, 175.73. MS m/z: 340 [(M+H)].
N-Isopropyl-3-(2-hydroxy-3-methylphenyl)-3-
phenylpropanamide 5b
IR (KBr): cm-1: 3024 (Aromatic C-H, str.), 2944, 2916,
2895 (Aliphatic C-H, str.), 1627 (C═O, str.), 1592, 1561
(C═C, str.), 1466, 1431 (CH2 bending), 1274 (C-N, str.),
1080 (C-O, str.), 779.8, 771 (Aromatic CH Out-of-plane
bend). 1H NMR (300 MHz, DMSO-d6) δ 0.9 (m, 6H),
2.16 (s, 3H), 2.69 (m, 2H), 3.69 (m, 1H), 4.74 (t, 1H), 6.6
(d, 1H), 6.76 (d, 2H), 7.08-7.2 (m, 5H), 7.64 (d, 1H). 13C
NMR (125 MHz, DMSO-d6) δ 16.78, 22.25, 39.0, 39.16,
39.33, 39.50, 39.59, 39.66, 39.83, 40.01, 41.04, 119.20,
124.58, 125.21, 125.62, 127.87, 128.36, 131.46, 144.53,
152.21, 169.60. MS m/z: 298 [(M +H)+].
N,N-diisopropyl-3-(2-hydroxy phenyl)-3-phenylpropanamide 4c
IR (KBr): cm-1: 3028 (Aromatic C-H, str.), 2944, 2871
(Aliphatic C-H, str.), 1627 (C═O, str.), 1557, 1497
(C═C, str.), 1469, 1452 (CH2 bending), 1270 (C-N, str.),
1073 (C-O, str.), 780,753 (Aromatic CH Out-of-plane
bend). 1H NMR (300 MHz, DMSO-d6) δ 1.04 (d, 12H),
2.089 (s, 3H), 2.79 (m, 2H), 3.037 (m, 2H), 4.702 (t, 1H), 6.6
(d, 1H), 6.75 (d, 2H), 7.127-7.246 (m, 5H). 13C NMR
(125 MHz, DMSO-d6) δ 20.25, 39.00, 39.17, 39.33, 39.50,
39.67, 39.83, 40.0, 42.53, 45.22, 116.14, 118.75, 125.51,126.51, 127.97, 132.36, 145.25, 154.92, 174.56. MS m/z: 326
[(M+H)+].
N-Isopropyl-3-(2-hydroxy phenyl)-3-phenylpropanamide 5c
IR (KBr): cm-1: 3027 (Aromatic C-H, str.), 2933, 2874
(Aliphatic C-H, str.), 1626 (C═O, str.), 1557, 1505
(C═C, str.), 1496, 1456 (CH2 bending), 1271 (C-N,
str.), 1081 (C-O, str.). 1H NMR (300 MHz, DMSO-d6)
δ 0.9 (m.6H), 2.16 (s, 3H), 2.69 (m, 2H), 3.69 (m, 1H),
4.74 (t, 1H), 6.6 (d, 1H), 6.76 (d, 2H), 7.08-7.2 (m, 5H),
7.64 (d, 1H). 13C NMR (125 MHz, DMSO-d6) δ 22.26,
22.28, 38.99, 39.16, 39.33, 39.50, 39.66, 39.73, 39.83,
39.93, 40.0, 40.65, 115.11, 118.725, 125.60, 126.84,
127.79, 130.47, 144.36, 154.48, 169.36. MS m/z: 284
[(M + H)+].
Data of the compounds 4-4c,5-5c
‘Additional file 1 complete spectral data. This material
can be found via the ‘Supplementary Content’ section of
this article’s web page’.
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